Opportunities > Singapore Art Museum 2022 call for residents
15 Aug 2022

Singapore Art Museum 2022 call for residents

SAM residencies banner

The Singapore Art Museum (SAM) is calling for applications from artists and researchers from all around the world for their residency programme. The Singapore-based, fully funded studio residencies will take place within a period of one to six months, between July 2023 and December 2024.

SAM Residencies is a museum-run programme committed to supporting the development of innovative artistic and curatorial practices that respond to current global discourses. Designed to engage both the art community and the public at large, SAM Residencies will actively involve local communities and the public through a diverse line-up of activities. 

This cycle focuses on notions of post-industrialism, critical alliances and/or the possibilities of a transformed future.

Up to 12 residents will be selected across three residency areas: 

  • Artist: open to artists and collectives who are looking to develop artistic practices and emergent modes of artmaking
  • Community and Education: open to practitioners who explore the relationship between art practice and forms of education or whose core practice engages with local communities or the public in various ways
  • Curatorial and Research: open to curators and researchers who are working on new modes of curatorial thinking and research processes

Support for residents

  • Return airfare 
  • Monthly stipend of SGD 1,500
  • Housing allowance
  • A studio space OR co-working space
  • An "ideas lab" – a shared space where anyone is free to post (physically), respond, explore and flesh out ideas-in-progress
  • Support from the museum and the Residencies team in the form of (but not limited to) institution resources and expertise, network building, opportunities for public engagement, and a scaffold for interaction and exchange

Application guidelines 

Deadline: 15 Aug 2022 

SAM presents contemporary art from a Southeast Asian perspective.